# Paradium.AI, Inc.: financial statements, quarterly

PAAI · NYSE · CIK 894871 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/paai.md) · [Financials](/companies/paai/financials.md) · [Filings](/companies/paai/filings.md) · [Insiders](/companies/paai/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/paai/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [37.0](/filings/0001493152-24-045851.md) | [44.1 d](/filings/0001641172-25-004921.md) | [28.9](/filings/0001641172-25-010882.md) | [27.2](/filings/0001628280-25-040284.md) | [33.6](/filings/0001628280-25-052003.md) | [36.2 d](/filings/0001628280-26-018153.md) | [31.8](/filings/0001628280-26-033427.md) | [45.0](/filings/0001628280-26-055208.md) | [29.8](/filings/0001628280-25-052003.md) | [28.2 d](/filings/0001628280-26-018153.md) | [20.4](/filings/0001628280-26-033427.md) | [22.2](/filings/0001628280-26-055208.md) |
| Cost of revenue | $m | [23.0](/filings/0001493152-24-045851.md) | [26.4 d](/filings/0001641172-25-004921.md) | [20.0](/filings/0001641172-25-010882.md) | [16.5](/filings/0001628280-25-040284.md) | [16.6](/filings/0001628280-25-052003.md) | [17.2 d](/filings/0001628280-26-018153.md) | [16.1](/filings/0001628280-26-033427.md) | [19.6](/filings/0001628280-26-055208.md) | [14.8](/filings/0001628280-25-052003.md) | [15.9 d](/filings/0001628280-26-018153.md) | [13.3](/filings/0001628280-26-033427.md) | [13.5](/filings/0001628280-26-055208.md) |
| Gross profit | $m | [14.0](/filings/0001493152-24-045851.md) | [17.8 d](/filings/0001641172-25-004921.md) | [8.9](/filings/0001641172-25-010882.md) | [10.7](/filings/0001628280-25-040284.md) | [17.0](/filings/0001628280-25-052003.md) | [19.1 d](/filings/0001628280-26-018153.md) | [15.7](/filings/0001628280-26-033427.md) | [25.4](/filings/0001628280-26-055208.md) | [14.9](/filings/0001628280-25-052003.md) | [12.3 d](/filings/0001628280-26-018153.md) | [7.1](/filings/0001628280-26-033427.md) | [8.7](/filings/0001628280-26-055208.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(4.5)](/filings/0001493152-24-045851.md) | [3.1 d](/filings/0001641172-25-004921.md) | [(8.0)](/filings/0001641172-25-010882.md) | [(2.6)](/filings/0001628280-25-040284.md) | [8.1](/filings/0001628280-25-052003.md) | [10.3 d](/filings/0001628280-26-018153.md) | [7.4](/filings/0001628280-26-033427.md) | [16.4](/filings/0001628280-26-055208.md) | [9.5](/filings/0001628280-25-052003.md) | [7.5 d](/filings/0001628280-26-018153.md) | [(0.3)](/filings/0001628280-26-033427.md) | [2.3](/filings/0001628280-26-055208.md) |
| Interest expense | $m | [4.0](/filings/0001493152-24-045851.md) | [4.7 d](/filings/0001641172-25-004921.md) | [4.3](/filings/0001641172-25-010882.md) | [4.2](/filings/0001493152-24-032945.md) | [3.2](/filings/0001493152-24-045851.md) | [2.9 d](/filings/0001628280-26-018153.md) | [3.0](/filings/0001628280-26-033427.md) | [2.9](/filings/0001628280-26-055208.md) | [2.8](/filings/0001628280-25-052003.md) | [2.6 d](/filings/0001628280-26-018153.md) | [2.4](/filings/0001628280-26-033427.md) | [2.5](/filings/0001628280-26-055208.md) |
| Income tax | $m | [0.1](/filings/0001493152-24-045851.md) | [0.1 d](/filings/0001641172-25-004921.md) | [0.0](/filings/0001641172-25-010882.md) | [0.0](/filings/0001628280-25-040284.md) | [0.0](/filings/0001628280-25-052003.md) | [0.1 d](/filings/0001628280-26-018153.md) | [0.3](/filings/0001628280-26-033427.md) | [1.0](/filings/0001628280-26-055208.md) | [(0.3)](/filings/0001628280-25-052003.md) | [(0.4) d](/filings/0001628280-26-018153.md) | [(0.1)](/filings/0001628280-26-033427.md) | [(0.1)](/filings/0001628280-26-055208.md) |
| Net income | $m | [(11.2)](/filings/0001493152-24-045851.md) | [(5.6) d](/filings/0001628280-26-028883.md) | [(103)](/filings/0001641172-25-010882.md) | [(8.2)](/filings/0001628280-25-040284.md) | [4.0](/filings/0001628280-25-052003.md) | [6.9 d](/filings/0001628280-26-028883.md) | [4.0](/filings/0001628280-26-033427.md) | [109](/filings/0001628280-26-055208.md) | [6.9](/filings/0001628280-25-052003.md) | [5.3 d](/filings/0001628280-26-028883.md) | [(2.7)](/filings/0001628280-26-033427.md) | [(0.2)](/filings/0001628280-26-055208.md) |
| Diluted EPS | $ per share | [(0.47)](/filings/0001493152-24-045851.md) | not reported | [(3.91)](/filings/0001641172-25-010882.md) | [(0.28)](/filings/0001628280-25-040284.md) | [0.11](/filings/0001628280-25-052003.md) | not reported | [0.08](/filings/0001628280-26-033427.md) | [2.28](/filings/0001628280-26-055208.md) | [0.14](/filings/0001628280-25-052003.md) | not reported | [(0.06)](/filings/0001628280-26-033427.md) | [0.00](/filings/0001628280-26-055208.md) |
| Basic EPS | $ per share | [(0.47)](/filings/0001493152-24-045851.md) | not reported | [(3.91)](/filings/0001641172-25-010882.md) | [(0.28)](/filings/0001628280-25-040284.md) | [0.11](/filings/0001628280-25-052003.md) | not reported | [0.08](/filings/0001628280-26-033427.md) | [2.29](/filings/0001628280-26-055208.md) | [0.14](/filings/0001628280-25-052003.md) | not reported | [(0.06)](/filings/0001628280-26-033427.md) | [0.00](/filings/0001628280-26-055208.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | period not labelled (2024-03-13) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.3](/filings/0001641172-25-004921.md) | not reported | [4.0](/filings/0001493152-24-020484.md) | [6.1](/filings/0001493152-24-032945.md) | [5.8](/filings/0001493152-24-045851.md) | [4.4](/filings/0001628280-26-018153.md) | [2.9](/filings/0001641172-25-010882.md) | [6.8](/filings/0001628280-25-040284.md) | [12.5](/filings/0001628280-25-052003.md) | [10.3](/filings/0001628280-26-055208.md) | [11.2](/filings/0001628280-26-033427.md) | [11.2](/filings/0001628280-26-055208.md) |
| Current assets | $m | [90.4](/filings/0001641172-25-004921.md) | not reported | [43.2](/filings/0001493152-24-020484.md) | [35.4](/filings/0001493152-24-032945.md) | [37.8](/filings/0001493152-24-045851.md) | [40.2](/filings/0001628280-26-018153.md) | [39.1](/filings/0001641172-25-010882.md) | [51.4](/filings/0001628280-25-040284.md) | [44.6](/filings/0001628280-25-052003.md) | [35.6](/filings/0001628280-26-055208.md) | [32.5](/filings/0001628280-26-033427.md) | [32.4](/filings/0001628280-26-055208.md) |
| Total assets | $m | [189](/filings/0001641172-25-004921.md) | not reported | [120](/filings/0001493152-24-020484.md) | [113](/filings/0001493152-24-032945.md) | [114](/filings/0001493152-24-045851.md) | [116](/filings/0001628280-26-018153.md) | [115](/filings/0001641172-25-010882.md) | [128](/filings/0001628280-25-040284.md) | [121](/filings/0001628280-25-052003.md) | [113](/filings/0001628280-26-055208.md) | [108](/filings/0001628280-26-033427.md) | [106](/filings/0001628280-26-055208.md) |
| Current liabilities | $m | [236](/filings/0001641172-25-004921.md) | not reported | [268](/filings/0001493152-24-020484.md) | [267](/filings/0001493152-24-032945.md) | [247](/filings/0001493152-24-045851.md) | [122](/filings/0001628280-26-018153.md) | [120](/filings/0001641172-25-010882.md) | [28.2](/filings/0001628280-25-040284.md) | [17.8](/filings/0001628280-25-052003.md) | [17.0](/filings/0001628280-26-055208.md) | [15.5](/filings/0001628280-26-033427.md) | [13.7](/filings/0001628280-26-055208.md) |
| Total liabilities | $m | [248](/filings/0001641172-25-004921.md) | not reported | [270](/filings/0001493152-24-020484.md) | [270](/filings/0001493152-24-032945.md) | [252](/filings/0001493152-24-045851.md) | [247](/filings/0001628280-26-018153.md) | [241](/filings/0001641172-25-010882.md) | [145](/filings/0001628280-25-040284.md) | [132](/filings/0001628280-25-052003.md) | [117](/filings/0001628280-26-055208.md) | [116](/filings/0001628280-26-033427.md) | [114](/filings/0001628280-26-055208.md) |
| Long-term debt | $m | [102](/filings/0001641172-25-004921.md) | not reported | [102](/filings/0001493152-24-020484.md) | [102](/filings/0001493152-24-032945.md) | [102](/filings/0001493152-24-045851.md) | [110](/filings/0001628280-26-018153.md) | [110](/filings/0001641172-25-010882.md) | [110](/filings/0001628280-25-040284.md) | [111](/filings/0001628280-25-052003.md) | [97.6](/filings/0001628280-26-055208.md) | [97.6](/filings/0001628280-26-033427.md) | [97.6](/filings/0001628280-26-055208.md) |
| Current portion of debt | $m | [102](/filings/0001641172-25-004921.md) | not reported | [102](/filings/0001493152-24-020484.md) | [102](/filings/0001493152-24-032945.md) | [102](/filings/0001493152-24-045851.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [102](/filings/0001493152-24-045851.md) | [7.7](/filings/0001493152-24-032945.md) | [102](/filings/0001493152-24-020484.md) | [102](/filings/0001493152-24-032945.md) | [102](/filings/0001493152-24-045851.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(59.0)](/filings/0001628280-26-018153.md) | not reported | [(150)](/filings/0001628280-25-040284.md) | [(157)](/filings/0001628280-25-052003.md) | [(137)](/filings/0001628280-25-052003.md) | [(130)](/filings/0001628280-26-055208.md) | [(126)](/filings/0001628280-26-055208.md) | [(17.3)](/filings/0001628280-26-055208.md) | [(10.4)](/filings/0001628280-25-052003.md) | [(4.8)](/filings/0001628280-26-055208.md) | [(7.4)](/filings/0001628280-26-055208.md) | [(7.6)](/filings/0001628280-26-055208.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(5.9) d](/filings/0001493152-24-045851.md) | [(2.5) d](/filings/0001641172-25-004921.md) | [(2.0)](/filings/0001641172-25-010882.md) | [(3.2) d](/filings/0001628280-25-040284.md) | [(2.3) d](/filings/0001628280-25-052003.md) | [(8.6) d](/filings/0001628280-26-018153.md) | [3.7](/filings/0001628280-26-033427.md) | [10.3 d](/filings/0001628280-26-055208.md) | [12.2 d](/filings/0001628280-25-052003.md) | [13.1 d](/filings/0001628280-26-018153.md) | [2.0](/filings/0001628280-26-033427.md) | [0.1 d](/filings/0001628280-26-055208.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-25-052003.md) | [0.0 d](/filings/0001628280-26-018153.md) | not reported | not reported | [0.0 d](/filings/0001628280-25-052003.md) | [0.0 d](/filings/0001628280-26-018153.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.3](/filings/0001493152-23-041192.md) | [18.7](/filings/0001493152-24-020484.md) | [22.1](/filings/0001493152-24-032945.md) | [23.4](/filings/0001493152-24-045851.md) | [26.4](/filings/0001641172-25-010882.md) | [29.4](/filings/0001628280-25-040284.md) | [37.6](/filings/0001628280-25-052003.md) | [47.5](/filings/0001628280-26-033427.md) | [47.6](/filings/0001628280-26-055208.md) | [47.7](/filings/0001628280-25-052003.md) | [47.5](/filings/0001628280-26-033427.md) | [47.5](/filings/0001628280-26-055208.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 47,610,653 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055208.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.